Long Term Outcomes of OCT Guided PCI in STEMI patients

Prior studies have shown the use of optical coherence tomography (OCT) have a significant influence on decision making, optimizing PCI and improving outcomes, vs conventional PCI. However, these studies have focused mainly on patients with stable angina or non-ST elevation MI. 

Resultados a largo plazo de la utilización de OCT para guiar ATC en pacientes con IAMCEST

The aim of this retrospective study was to find out whether the use of OCT can reduce mortality at long term (5 years) vs. PCI alone in patients with ST elevation MI (STEMI). 

Primary end point was all-cause mortality rate, and secondary end point was cardiovascular mortality rate.

3,897 were enrolled: 69.2% were treated with OCT and 30.8% with PCI alone. Mean patient age was approximately 60, and most patients were men. Among OCT patients, the most affected artery was the anterior descending, while in the PCI alone group, it was the right coronary. 

OCT guided patients were treated with stents less frequently during PCI (62.6% vs 80.2%; p<0.001). At 5 years, accumulated all-cause mortality and cardiovascular rates in the OCT guided cohort were 10.4% and 8.0%, respectively, significantly lower than the PCI alone cohort (19.0% and 14.1%; p<0.001).

Read also: Definite Pacemaker Implantation Predictors in TAVR High Implant Using Cusp Overlap.

Multivariable models showed the use of OCT might significantly reduce all-cause mortality at 5 years (HR: 0.689, CI 95%: 0.551-0.862) and cardiovascular mortality (HR: 0.692, IC 95%: 0.536-0.895). After propensity score matching for homogenous samples, the benefits of OCT guided PCI remained consistent in terms of all-cause (HR: 0.707, CI 95%: 0.548-0.913) and cardiovascular mortality (HR: 0.709, CI 95%: 0.526-0.955).

Conclusion

In this observational study, the use of OCT during PCI in patients with STEMI was associated to reduced mortality at long term vs. PCI alone. However, we need prospective randomized studies to confirm these results. 

Original Title: Five-year follow-up of OCT-guided percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Reference: Luping He, MD et al EuroIntervention 2024;20:e937-e947.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...